Position history for Pentwater Capital Management LP's holdings in ATRIUM THERAPEUTICS INC
Pentwater Capital Management LP holds 602,649 shares of RNA (ATRIUM THERAPEUTICS INC), worth $8.1M as of 2026-Q1. This is a new position. RNA represents 0.0% of Pentwater Capital Management LP's portfolio.
Current Value
$8.1M
Current Shares
602,649
Total Value Change
$0
Total Shares Change
0
Other major holders of RNA: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC
New |
| 602,649 |
- |
| $8.1M |
| 0.0% |
| $15.67 |
38 |